Combined Treatment of Brain AVMs with Use of Onyx Embolization followed by Radiosurgery

REFERENCES

1. 1.↵
   1. Forsting M

   1. Cognard C,
   2. Spelle L,
   3. Pierot L

   . Pial arteriovenous malformations. In: Forsting M, ed. Intracranial Vascular Malformations and Aneurysms. Berlin: Springer-Verlag; 2004:39–100
2. 2.↵
   1. Pierot L,
   2. Januel AC,
   3. Herbreteau D,
   4. et al

   . Endovascular treatment of brain arteriovenous malformations using Onyx: results of a prospective, multicenter study. J Neuroradiol 2009;36:147–52

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Loh Y,
   2. Duckwiler GR

   , for the Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 2010;113:733–41

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Saatci I,
   2. Geyik S,
   3. Yavuz K,
   4. et al

   . Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg 2011;115:78–88

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Pan JW,
   2. Zhou HJ,
   3. Zhan RY,
   4. et al

   . Supratentorial brain AVM embolization with Onyx-18 and post-embolization management. A single-center experience. Interv Neuroradiol 2009;15:275–82

   Abstract/FREE Full Text
6. 6.↵
   1. Andrade-Souza YM,
   2. Ramani M,
   3. Scora D,
   4. et al

   . Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations. Neurosurgery 2007;60:443–51; discussion 451–52

   PubMed
7. 7.↵
   1. Back AG,
   2. Vollmer D,
   3. Zeck O,
   4. et al

   . Retrospective analysis of unstaged and staged gamma knife surgery with and without preceding embolization for the treatment of arteriovenous malformations. J Neurosurg 2008;109 Suppl:57–64

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Zabel du Bois A,
   2. Milker-Zabel S,
   3. Huber P,
   4. et al

   . Risk of hemorrhage and obliteration rates of LINAC-based radiosurgery for cerebral arteriovenous malformations treated after prior partial embolization. Int J Radiation Oncology Biol Phys 2007;68:999–1003

   CrossRefPubMed
9. 9.↵
   1. Blackburn SL,
   2. Ashley WW Jr.,
   3. Rich KM,
   4. et al

   . Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg 2011;114:1758–67

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Spetzler RF,
    2. Martin NA

    . A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Pierot L,
    2. Casasco A,
    3. Cognard C,
    4. et al

    . Embolisation des MAV cérébrales à l'Onyx: résultats de l'étude BRAVO. J Neuroradiol 2011;38:11
12. 12.↵
    1. Weber W,
    2. Kis B,
    3. Siekmann R,
    4. et al

    . Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 2007;61:244–52; discussion 252–54

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Xu F,
    2. Ni W,
    3. Liao Y,
    4. et al

    . Onyx embolization for the treatment of brain arteriovenous malformations. Acta Neurochir (Wien) 2011;153:869–78

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Douglas JG,
    2. Goodkin R

    . Treatment of arteriovenous malformations using gamma knife surgery: the experience at the University of Washington from 2000 to 2005. J Neurosurg 2008;109 Suppl:51–56

    PubMed
15. 15.↵
    1. Shtraus N,
    2. Schifter D,
    3. Corn BW,
    4. et al

    . Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted. J Neurooncol 2010;98:271–76

    CrossRefPubMed
16. 16.↵
    1. Mamalui-Hunter M,
    2. Jiang T,
    3. Rich KM,
    4. et al

    . Effect of liquid embolic agents on gamma knife surgery dosimetry for arteriovenous malformations. Clinical article. J Neurosurg 2011;115:364–70

    CrossRefPubMed